VCYT Veracyte Inc
Company Analysis
Latest News
🟢 Veracyte is trading 4.38% up today with no clear catalyst identified
Veracyte is trading 4.38% higher at $47.42 on September 28, 2026, with no clear company-specific catalyst identified for the move. - The latest reported...
🔴 Veracyte is trading 4.01% down today with no clear company-specific catalyst
Veracyte is trading 4.01% down at $46.59, with no clear company-specific catalyst identified for September 25, 2026. - Its press-release page shows no new...
🟢 Veracyte is trading 10% up today with no identified catalyst
Veracyte is trading 10.43% higher at $48.39, and the September 24, 2026 move remains unexplained. - No company-specific announcement, analyst action, or other...
🟢 Veracyte is trading 5% up today with no company-specific catalyst identified
Veracyte is trading 5.19% higher at $46.09, with no company-specific announcement or analyst action dated September 24 identified to explain the move. - It...
🔴 Veracyte is trading at 20.89% down in after-hours trading with no verified company-specific catalyst identified
Veracyte is trading 20.89% lower at $34.30 after-hours, following a September 22, 2026 close at $43.36; available coverage identifies no new company-specific...
🟢 Veracyte rises 4.2% — Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is trading higher, driven by a...
🔴 Veracyte is trading 7.9% down in pre-market with no clear company-specific catalyst
Veracyte is trading 7.9% down at $38.25, with no clear company-specific catalyst identified for September 22, 2026. - Its latest major announcement was the...
🟢 Veracyte is trading 4.1% up today as Nasdaq rose 1.75%
Veracyte is trading 4.1% up at $41.43, most consistent with broader risk-on sentiment after the Nasdaq rose 1.75% and the S&P 500 gained 1.19%. - No new...
🟢 Veracyte rises 4.2% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Veracyte is trading 4.31% down today amid biotech-sector weakness
Veracyte is trading 4.31% down now at $38.41 as biotech shares weaken and broader markets sell off amid higher rates and persistent inflation concerns. - No...
🔴 Veracyte falls 4.3% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
Veracyte Acquires Convergent Genomics for $150M to Expand Urology Diagnostics Portfolio
Veracyte (VCYT) announced it has completed the acquisition of Convergent Genomics, a diagnostics company focused on bladder cancer. The acquisition expands...
🔴 Veracyte is trading 4% down today after hotter-than-expected producer inflation
Veracyte is trading 4% down now at $42.10 after hotter-than-expected producer inflation and reduced expectations for near-term Federal Reserve easing. - The...